Dividend Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.40 USD | +0.69% |
|
+2.31% | -19.61% |
EPS & Dividend: Charles River Laboratories International, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 7.2 | 7.6 | 9.48 | 9.22 | 0.2 | 4.512 | 5.785 | 6.708 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 247.17 | 371.96 | 215.04 | 238.78 | 186.16 | 148.40 | 148.40 | 148.40 |
| Nbr of stocks (in thousands) | 49,743 | 50,464 | 50,879 | 51,297 | 51,136 | 49,116 | - | - |
| Announcement Date | 17/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | 19/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Charles River Laboratories International, Inc.
| 29/07/2025 | Q2 2025 Earnings Release (Projected) |
| 28/10/2025 | Q3 2025 Earnings Release (Projected) |
| 17/02/2026 | Q4 2025 Earnings Release (Projected) |
| 06/05/2026 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 32.66x | 2.14x | 2.41x | ||
| 0.87% | 1% | 38.8x | 4.03x | 5.65x | ||
| -.--% | -.--% | 164.91x | 7.43x | 5.56x | ||
| -.--% | -.--% | 20.75x | 4.04x | 2.45x | ||
| 0.45% | 0.42% | 41x | 1.98x | 8.52x | ||
| 1.16% | 1.29% | 22.29x | 2.06x | 1.9x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 15.83x | 1.18x | 1.8x | ||
| -.--% | -.--% | -43.26x | 44.06x | 9.57x | ||
| -.--% | -.--% | -41.11x | -50.08x | 15.6x | ||
| Average | 0.28% | 0.3% | 27.98x | 1.87x | 5.94x | |
| Weighted average by Cap. | 0.37% | 0.41% | 45.11x | 3.35x | 5.77x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition